Skip to content

Accuracy of Noninvasive Hemoglobin Measurement (SpHb) Using Rainbow DCI Pulse Oximeter Sensor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03124693
Enrollment
90
Registered
2017-04-24
Start date
2008-08-12
Completion date
2008-09-09
Last updated
2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Surgery

Brief summary

In this study, the concentration of hemoglobin within the subject's blood is affected by fluid status changes. The fluid status is affected by fluid loss during surgery for hospitalized study subjects or controlled administration of fluids intravenously for healthy study volunteers. The accuracy of a noninvasive hemoglobin sensor(s) will be assessed by comparing with blood sample analysis.

Interventions

DEVICERainbow DCI pulse oximeter sensor

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy Volunteers Inclusion Criteria: * Has physical status between ASA 1 or 2 * Able to communicate in English

Exclusion criteria

* Pregnant or sexually active without birth control. * Hemoglobin less than 11g/dL * Known alcohol or drug abuse * Skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection * Nail polish * Head injury with loss of consciousness within the last year * Known neurological and psychiatric conditions. * Known concurrent chronic usage of psychoactive or anti-convulsive drugs within the last 90 days, or use in the last 7 days (i.e. tricyclic antidepressants, MAO inhibitors, lithium, neuroleptics, anxiolytics or antipsychotics. Except SSRIs * Subject has any medical condition which, in the judgement of the investigator, renders them inappropriate for participation in this study, such as Reynauds syndrome * Hypertension: Systolic BP \>= 140 mmHg or Diastolic BP \>= 90 mmHg * Baseline heart rate \<50 beats per minute Surgical Subjects Inclusion Criteria: * Age \> 18 years old * Scheduled for surgery requiring frequent schedule blood draws as a part of their routine care

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Sensor by Arms CalculationUp to 24 hoursAccuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value.

Countries

United States

Participant flow

Participants by arm

ArmCount
Test Group
All subjects are enrolled into the test group and all subjects received the Rainbow DCI pulse oximeter sensor. Rainbow DCI pulse oximeter sensor
90
Total90

Baseline characteristics

CharacteristicTest Group
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
90 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
90 participants
Sex: Female, Male
Female
18 Participants
Sex: Female, Male
Male
72 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 90
serious
Total, serious adverse events
0 / 90

Outcome results

Primary

Accuracy of Sensor by Arms Calculation

Accuracy will be determined by comparing the noninvasive hemoglobin measurement of the pulse oximeter to the hemoglobin value obtained from a blood sample and calculating the arithmetic root mean square (Arms) error value.

Time frame: Up to 24 hours

ArmMeasureValue (NUMBER)
Test GroupAccuracy of Sensor by Arms Calculation0.9 g/dL

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026